180 related articles for article (PubMed ID: 8211550)
1. [Platelet function after allogeneic bone marrow transplantation in Wiskott-Aldrich syndrome].
Megido M; Cesar JM; Maldonado MS; Otheo E; Muñoz A; Navarro JL
Sangre (Barc); 1993 Jun; 38(3):233-4. PubMed ID: 8211550
[TBL] [Abstract][Full Text] [Related]
2. [Allogenic bone marrow transplantation in Wiskott-Aldrich syndrome].
Maldonado MS; Muñoz A; Otheo de Tejada E; Roldán E; Aymerich L; Brieva JA
Med Clin (Barc); 1993 Sep; 101(7):258-60. PubMed ID: 7746001
[TBL] [Abstract][Full Text] [Related]
3. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.
Kobayashi R; Ariga T; Nonoyama S; Kanegane H; Tsuchiya S; Morio T; Yabe H; Nagatoshi Y; Kawa K; Tabuchi K; Tsuchida M; Miyawaki T; Kato S
Br J Haematol; 2006 Nov; 135(3):362-6. PubMed ID: 17032176
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
5. Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia.
Flood VH; Johnson FL; Boshkov LK; Thomas GA; Nugent DJ; Bakke AC; Nicholson HS; Tilford D; Brown MP; Godder KT
Pediatr Blood Cancer; 2005 Dec; 45(7):971-5. PubMed ID: 15768382
[TBL] [Abstract][Full Text] [Related]
6. Unrelated donor BMT for Wiskott-Aldrich syndrome.
Lenarsky C; Weinberg K; Kohn DB; Parkman R
Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361
[TBL] [Abstract][Full Text] [Related]
7. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
Rosales F; Peylan-Ramu N; Cividalli G; Varadi G; Or R; Naparstek E; Slavin S; Nagler A
Bone Marrow Transplant; 1999 May; 23(9):861-5. PubMed ID: 10338039
[TBL] [Abstract][Full Text] [Related]
8. Results of allogeneic bone marrow transplant in chronic myeloid leukaemia following conditioning with busulfan and cyclophosphamide.
Saikia TK; Advani SH; Parikh PM; Bapna A; Somjee S; Mukhopadhyay A; Gopal R; Nair CN
J Assoc Physicians India; 1999 Aug; 47(8):770-3. PubMed ID: 10778619
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of the Wiskott-Aldrich syndrome by a graft of allogeneic bone marrow].
Fischer A; Durandy A; Bordigoni P; Virelizier JL; Vilmer E; Arnaud-Battandier F; Lagrue A; Olive D; Griscelli C
Arch Fr Pediatr; 1984 Nov; 41(9):611-6. PubMed ID: 6391414
[TBL] [Abstract][Full Text] [Related]
11. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
Parkman R; Rappeport J; Geha R; Belli J; Cassady R; Levey R; Nathan DG; Rosen FS
N Engl J Med; 1978 Apr; 298(17):921-7. PubMed ID: 347289
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related complex treated by antiviral drugs and allogeneic bone marrow transplantation following conditioning protocol with busulphan, cyclophosphamide and cyclosporin.
Torlontano G; Di Bartolomeo P; Di Girolamo G; Angrilli F; Verani P; Maggiorella MT; Dragani A; Iacone A; Papalinetti G; Olioso P
Haematologica; 1992; 77(3):287-90. PubMed ID: 1427437
[TBL] [Abstract][Full Text] [Related]
13. Restoration of neutrophil and platelet function in feline Chediak-Higashi syndrome by bone marrow transplantation.
Colgan SP; Hull-Thrall MA; Gasper PW; Gould DH; Rose BJ; Fulton R; Blanquaert AM; Bruyninckx WJ
Bone Marrow Transplant; 1991 May; 7(5):365-74. PubMed ID: 2070146
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants.
Beguin Y; Oris R; Fillet G
Bone Marrow Transplant; 1993 Apr; 11(4):285-92. PubMed ID: 8485476
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
16. Accidental busulfan overdose: enhanced drug clearance with hemodialysis in a child with Wiskott-Aldrich syndrome.
Stein J; Davidovitz M; Yaniv I; Ben-Ari J; Gamzu Z; Hoffer E; Bentur Y; Tabak A; Krivoy N
Bone Marrow Transplant; 2001 Mar; 27(5):551-3. PubMed ID: 11313692
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of X-linked polymorphic loci as gene markers to track X allele and chimerism in a post-allogeneic peripheral blood stem cell transplant patient with Wiskott-Aldrich syndrome.
Sasanakul W; Hongeng S; Chuansumrit A; Chaiyaratana W; Pakakasama S; Hathirat P
J Med Assoc Thai; 2001 Mar; 84(3):379-84. PubMed ID: 11460939
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of destruction and regeneration of the haemopoietic system after administration of busulphan and cyclophosphamide followed by bone marrow transplantation. Peripheral blood parameters.
Szczylik C; Ratajczak MZ; Urbanowska E; Jedrzejczak WW
Acta Med Pol; 1989; 30(3-4):93-109. PubMed ID: 2519630
[TBL] [Abstract][Full Text] [Related]
19. [Ultrastructure of the blood platelets in Wiskott-Aldrich syndrome].
Trung PH; Griscelli C; Mozziconacci P
Pathol Biol (Paris); 1975 Jan; 23(1):57-62. PubMed ID: 1105327
[TBL] [Abstract][Full Text] [Related]
20. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
